Rhinoconjunctivitis

Showing 1 - 25 of 47

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Hypersensitivity, Hay Fever, Rhinitis, Allergic, Seasonal Trial (Polvac Grass+Rye)

Not yet recruiting
  • Hypersensitivity
  • +3 more
  • Polvac Grass+Rye
  • (no location specified)
Jul 17, 2023

Grass Pollen Allergy, Rhinoconjunctivitis Trial in Aarhus (Motivation-enhancing intervention, Standard intervention)

Recruiting
  • Grass Pollen Allergy
  • Rhinoconjunctivitis
  • Motivation-enhancing intervention
  • Standard intervention
  • Aarhus, Denmark
    Anne Poder Petersen
Nov 18, 2022

Seasonal Allergic Rhinitis, Rhinoconjunctivitis Trial (PQ Grass, Placebo)

Not yet recruiting
  • Seasonal Allergic Rhinitis
  • Rhinoconjunctivitis
  • PQ Grass
  • Placebo
  • (no location specified)
Sep 12, 2022

Rhinitis, Allergic, Rhinoconjunctivitis, Asthma, Allergic Trial in Spain (10,000 MM09, 30,000 MM09, Placebo subcutaneous)

Recruiting
  • Rhinitis, Allergic
  • +2 more
  • 10,000 MM09
  • +2 more
  • Elche, Alicante, Spain
  • +16 more
Mar 23, 2022

Type 1 Diabetes, Allergic Rhinitis, Allergic Asthma Trial in Valencia (Ten Vida (10Vida))

Recruiting
  • Type 1 Diabetes
  • +10 more
  • Ten Vida (10Vida)
  • Valencia, Spain
    University of Valencia
Mar 18, 2022

Rhinitis, Rhinoconjunctivitis Trial in Spain (MG56 Mannosylated 500 subcutaneous, MG56 Mannosylated 1000 subcutaneous, MG56

Completed
  • Rhinitis
  • Rhinoconjunctivitis
  • MG56 Mannosylated 500 subcutaneous
  • +9 more
  • Aranjuez, Madrid, Spain
  • +11 more
Jan 12, 2022

"Allergovac Poliplus" in Polysensitized Allergic

Completed
  • Rhinitis, Allergic
  • Rhinoconjunctivitis
  • Allergen Immunotherapy (AIT)
  • Cornellà De Llobregat, Barcelona, Spain
  • +9 more
Oct 19, 2021

Rhinitis, Allergic, Rhinoconjunctivitis, Asthma, Allergic Trial in Spain (10,000 MG01 +10,000 T521, 30,000 MG01 +10,000 T521,

Recruiting
  • Rhinitis, Allergic
  • +2 more
  • 10,000 MG01 +10,000 T521
  • +2 more
  • Tarancon, Cuenca, Spain
  • +13 more
Aug 13, 2021

Allergic Rhinitis, Allergy to Pollen, Rhinoconjunctivitis Trial in Strasbourg (Exposure to , Exposure to allergen)

Completed
  • Allergic Rhinitis
  • +2 more
  • Exposure to placebo
  • Exposure to allergen
  • Strasbourg, Grand Est, France
    Alyatec
Jun 8, 2021

Rhinitis, Rhinoconjunctivitis Trial in Spain (MM09 Mannosylated 5.000 subcutaneous, MM09 Mannosylated 10.000 subcutaneous, MM09

Unknown status
  • Rhinitis
  • Rhinoconjunctivitis
  • MM09 Mannosylated 5.000 subcutaneous
  • +9 more
  • Elche, Alicante, Spain
  • +13 more
Mar 10, 2020

Seasonal Allergic Rhinitis, Hay Fever, Rhinoconjunctivitis Trial in Mississauga (Bilastine, Placebo)

Completed
  • Seasonal Allergic Rhinitis
  • +2 more
  • Mississauga, Ontario, Canada
    Allied Research International - Cetero Research
Feb 13, 2019

"Allergovac Poliplus" in Polysensitized Rhinitis or Allergic

Completed
  • Allergic Rhinitis
  • +2 more
  • Allergovac Poliplus
  • A Coruna, Spain
  • +14 more
Jan 24, 2019

Allergic Rhinitis, Rhinoconjunctivitis, Exposure Trial in Ottawa (Allergen Exposure)

Completed
  • Allergic Rhinitis
  • +2 more
  • Allergen Exposure
  • Ottawa, Ontario, Canada
    Ottawa Allergy Research Corporation
Aug 23, 2018

Rhinitis, Rhinoconjunctivitis, Asthma Trial in Santiago de Compostela, Santa Cruz de Tenerife, Lugo (DP/MG/14-1, DP/MG/14-2)

Completed
  • Rhinitis
  • +2 more
  • DP/MG/14-1
  • DP/MG/14-2
  • Santiago de Compostela, A Coruña, Spain
  • +2 more
Aug 7, 2018

Rhinoconjunctivitis Trial in Worldwide (Cat-PAD, Placebo)

Completed
  • Rhinoconjunctivitis
  • Rolling Hills Estates, California
  • +117 more
May 16, 2018

Rhinoconjunctivitis Trial in Worldwide (HDM-SPIRE, Placebo)

Completed
  • Rhinoconjunctivitis
  • Birmingham, Alabama
  • +97 more
May 16, 2018

Rhinoconjunctivitis Trial in Lodz, Tarnow, Warsaw (Cat-PAD, Placebo)

Completed
  • Rhinoconjunctivitis
  • Lodz, Poland
  • +2 more
May 11, 2018

Allergic Rhinitis, Rhinoconjunctivitis, Mild Persistent Asthma Trial in Spain (Depigoid® (500 DPP/ml))

Terminated
  • Allergic Rhinitis
  • +3 more
  • Depigoid® (500 DPP/ml)
  • Almería, Andalucía, Spain
  • +9 more
Feb 21, 2018

Rhinoconjunctivitis Trial in Spain (Allergovac depot with Olea europaea pollen extract)

Completed
  • Rhinoconjunctivitis
  • Allergovac depot with Olea europaea pollen extract
  • Jaén, Andalucía, Spain
  • +4 more
Oct 20, 2017

Rhinoconjunctivitis Trial in Spain (Allergovac depot with Parietaria judaica pollen extract)

Completed
  • Rhinoconjunctivitis
  • Allergovac depot with Parietaria judaica pollen extract
  • Orihuela, Alicante, Spain
  • +3 more
Apr 28, 2017

Rhinoconjunctivitis, Rhinitis, Conjunctivitis Trial (Placebo, SCH 697243, Loratadine 10 mg Rescue Treatment)

Completed
  • Rhinoconjunctivitis
  • +3 more
  • Placebo
  • +8 more
  • (no location specified)
Jan 18, 2017

Rhinoconjunctivitis, Rhinitis, Conjunctivitis Trial (Placebo, SCH 39641)

Completed
  • Rhinoconjunctivitis
  • +3 more
  • Placebo
  • SCH 39641
  • (no location specified)
Jan 18, 2017

Rhinoconjunctivitis, Rhinitis, Conjunctivitis Trial (Placebo, SCH 697243, Loratadine Syrup 1 mg/mL Rescue Treatment)

Completed
  • Rhinoconjunctivitis
  • +3 more
  • Placebo
  • +8 more
  • (no location specified)
Jan 18, 2017

Ragweed-SPIRE Follow-On Study

Completed
  • Rhinoconjunctivitis
  • Ragweed Allergy
    • Kanata, Ontario, Canada
    • +2 more
    Mar 22, 2016

    Allergic Rhinitis, Rhinoconjunctivitis Trial in Worldwide (, AllerT low dose, AllerT full dose)

    Completed
    • Allergic Rhinitis
    • Rhinoconjunctivitis
    • placebo
    • +2 more
    • Hellerup, Copenhagen, Denmark
    • +23 more
    Mar 30, 2015